BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2011
View Archived Issues
Encouraging phase I data presented on GDC-0068 and GDC-0941 in cancer
Read More
Cixutumumab monotherapy is not beneficial in phase II hepatocellular carcinoma trial
Read More
Preliminary first-in-human results indicate ATU-027 RNAi therapy is well tolerated
Read More
New modulators of lysophospholipid S1P1 receptor presented
Read More
Phase III trial evaluates linagliptin/metformin combination in type 2 diabetes
Read More
Boehringer Ingelheim discloses new ribosomal protein S6 kinase alpha-3 inhibitors
Read More
Galderma presents novel peroxide derivatives for acne
Read More
CNX-011-67 improves responsiveness to glucose in models of diabetes
Read More
BioAlliance Pharma submits application to French Drug Agency for phase III Livatag trial
Read More
Phase I trial assesses TPI-287 with and without temozolomide in neuroblastoma/medulloblastoma
Read More
EpiCept receives initial responses from FDA regarding SPA application for Ceplene in AML
Read More
Living Cell Technologies begins enrollment in phase II Diabecell trial
Read More
Scientists at Sanofi design new pim kinase inhibitors for cancer
Read More
Dosing begins in phase I trial of antisense therapy ATL-1103
Read More
Japanese MAA submitted for Eylea for wet AMD
Read More
Medivir patents new cathepsin S inhibitors
Read More
Cardium Therapeutics to acquire Transdel Pharmaceuticals
Read More
FDA grants orphan drug status to anticancer product MDX-1097
Read More
Cynapsus provides update on oral apomorphine for Parkinson's disease
Read More
CHMP recommends approval of Eurartesim for malaria
Read More
Enrollment complete in phase III MOTION trial of safinamide in early Parkinson's disease
Read More
Health Canada approves Tasigna for newly diagnosed Ph+ CML
Read More
FDA accepts for review Pfizer's application for axitinib in advanced renal cell carcinoma
Read More
Progenics submits sNDA for Relistor for OIC in patients with chronic noncancer pain
Read More
Phase I/II trial of 2B3-101 to begin in patients with brain metastases
Read More
Torrent Pharmaceuticals' new HSP70 inducer TRC-051384 reduces symptoms of stroke in vivo
Read More